Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
61.03
-56.03
-91.81%
Share Warrants & Outstandings
Total Reserve
1.97
35.10
-33.13
-94.39%
Shareholder's Funds
6.97
96.13
-89.16
-92.75%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.62
0.00
2.62
0.00%
Secured Loans
1.51
0.00
1.51
0.00%
Unsecured Loans
1.11
0.00
1.11
0.00%
Deferred Tax Assets / Liabilities
-0.07
-3.94
3.87
98.22%
Other Long Term Liabilities
0.25
0.97
-0.72
-74.23%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.34
-1.34
-100.00%
Total Non-Current Liabilities
2.80
-1.63
4.43
271.78%
Current Liabilities
Trade Payables
1.31
2.52
-1.21
-48.02%
Other Current Liabilities
3.04
5.61
-2.57
-45.81%
Short Term Borrowings
7.74
0.00
7.74
0.00%
Short Term Provisions
0.00
4.45
-4.45
-100.00%
Total Current Liabilities
12.08
12.59
-0.51
-4.05%
Total Liabilities
21.85
107.09
-85.24
-79.60%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.86
116.29
-114.43
-98.40%
Less: Accumulated Depreciation
0.87
55.43
-54.56
-98.43%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.99
60.87
-59.88
-98.37%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
3.57
-3.57
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
5.25
-5.25
-100.00%
Other Non Current Assets
1.12
1.41
-0.29
-20.57%
Total Non-Current Assets
2.11
71.10
-68.99
-97.03%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.06
0.00
7.06
0.00%
Sundry Debtors
5.64
7.45
-1.81
-24.30%
Cash and Bank
5.21
26.70
-21.49
-80.49%
Other Current Assets
0.00
0.90
-0.90
-100.00%
Short Term Loans and Advances
1.82
0.94
0.88
93.62%
Total Current Assets
19.74
35.99
-16.25
-45.15%
Net Current Assets (Including Current Investments)
7.65
23.40
-15.75
-67.31%
Total Current Assets Excluding Current Investments
19.74
35.99
-16.25
-45.15%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
21.85
107.09
-85.24
-79.60%
Contingent Liabilities
0.00
13.23
-13.23
-100.00%
Total Debt
10.36
0.00
10.36
0.00%
Book Value per share (adjusted)
13.93
15.75
-1.82
-11.56%
Annual - Borrowings
Borrowings 10.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 19.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024






